These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24504230)

  • 1. Viral safety perspective from the Paul-Ehrlich-Institut in Europe.
    Blümel J
    PDA J Pharm Sci Technol; 2014; 68(1):11-2. PubMed ID: 24504230
    [No Abstract]   [Full Text] [Related]  

  • 2. [Allergens for specific immunotherapy: authorization and quality criteria of the Paul-Ehrlich-Institut].
    May S; Kaul S; Schröder C; Vieths S
    Hautarzt; 2006 Oct; 57(10):867-74. PubMed ID: 16977441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety monitoring of cell-based medicinal products (CBMPs)].
    Funk MB; Frech M; Spranger R; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1239-46. PubMed ID: 26391098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Innovation Office of the Paul-Ehrlich-Institut. Regulatory support during the scientific development of ATMP].
    Ziegele B; Dahl L; Müller AT
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):857-66. PubMed ID: 21698540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Paul Ehrlich (1854-1915) and his contacts with East European physicians at the time of testing the first chemioterapeutics].
    Schneck P
    Arch Hist Filoz Med; 1996; 59(1):41-8. PubMed ID: 11619177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the past Paul Ehrlich seminars.
    Siefert G
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1988; (82):XII-XV. PubMed ID: 3196012
    [No Abstract]   [Full Text] [Related]  

  • 7. [Paul Ehrlich and his contacts with the scientists of Eastern Europe].
    Schneck P
    Probl Sotsialnoi Gig Istor Med; 1996; (6):56-8. PubMed ID: 9235276
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the relevance of the target animal safety test for the quality control of veterinary immunological medicinal products.
    Pöbetanecker A; Cubetaler K
    ALTEX; 1998; 15(5):71-75. PubMed ID: 11178548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Letters from the Nobellaureter Paul Ehrlich to the Director for the State Serum Institute in Copenhagen, Thorvald Madsen].
    Kristiansen JE; Hendricks O; Permin H
    Dan Medicinhist Arbog; 2004; ():173-91. PubMed ID: 15685791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paul Ehrlich: magister mundi.
    Drews J
    Nat Rev Drug Discov; 2004 Sep; 3(9):797-801. PubMed ID: 15340389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History and future of allergen standardization and of the Paul-Ehrlich-Seminar.
    de Weck AL
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):317-27. PubMed ID: 15119052
    [No Abstract]   [Full Text] [Related]  

  • 12. [After the TGN1412 incident. Principles for assessment of first-in-man trials with monoclonal antibodies by the Paul Ehrlich Institute].
    Schneider CK; Kalinke U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Oct; 50(10):1213-20. PubMed ID: 17924065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paul Ehrlich--in search of the magic bullet.
    Winau F; Westphal O; Winau R
    Microbes Infect; 2004 Jul; 6(8):786-9. PubMed ID: 15207826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paul Ehrlich: the Nobel Prize in physiology or medicine 1908.
    Piro A; Tagarelli A; Tagarelli G; Lagonia P; Quattrone A
    Int Rev Immunol; 2008; 27(1-2):1-17. PubMed ID: 18300053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies for use in man: current regulatory situation in the Federal Republic of Germany.
    Haase M
    Dev Biol Stand; 1990; 71():213-20. PubMed ID: 2205526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Workshop on Animal free Detection of Pertussis Toxin in Vaccines--Alternatives to the Histamine Sensitisation Test.
    Bache C; Hoonakker M; Hendriksen C; Buchheit KH; Spreitzer I; Montag T
    Biologicals; 2012 Jul; 40(4):309-11. PubMed ID: 22609106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paul Ehrlich (1854-1915): founder of chemotherapy and pioneer of haematology, immunology and oncology.
    Androutsos G
    J BUON; 2004; 9(4):485-91. PubMed ID: 17415859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The return of Ehrlich's 'Therapia magna sterilisans' and other Ehrlich concepts?. Series of papers honoring Paul Ehrlich on the occasion of his 150th birthday.
    Sörgel F
    Chemotherapy; 2004 Apr; 50(1):6-10. PubMed ID: 15084798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ilya Ilich Metchnikov and Paul Ehrlich: 1908 Nobel Prize winners for their research on immunity].
    Lokaj J; John C
    Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):119-24. PubMed ID: 19069024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory acceptance and use of serology for inactivated veterinary rabies vaccines.
    Schiffelers MJ; Blaauboer BJ; Bakker WE; Hendriksen CF
    ALTEX; 2015; 32(3):211-21. PubMed ID: 25936354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.